213 related articles for article (PubMed ID: 30156605)
1. Predictors of Family Enrollment in a Genetic Cascade Screening Program for Familial Hypercholesterolemia.
Silva PRS; Jannes CE; Oliveira TGM; Gómez LMG; Krieger JE; Santos RD; Pereira AC
Arq Bras Cardiol; 2018 Oct; 111(4):578-584. PubMed ID: 30156605
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil.
Silva PRS; Jannes CE; Oliveira TGM; Miname MH; Rocha VZ; Chacra AP; Gurgel MHC; Montenegro RM; Rodrigues Sobrinho CRM; Bello Moreira AS; Assad MHV; Pinto MRC; Tada MT; Santos RD; Pereira AC; Krieger JE
Atherosclerosis; 2017 Aug; 263():257-262. PubMed ID: 28689098
[TBL] [Abstract][Full Text] [Related]
3. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
[TBL] [Abstract][Full Text] [Related]
4. Predictors of cardiovascular events after one year of molecular screening for Familial hypercholesterolemia.
Silva PR; Jannes CE; Marsiglia JD; Krieger JE; Santos RD; Pereira AC
Atherosclerosis; 2016 Jul; 250():144-50. PubMed ID: 27214396
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
6. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
[TBL] [Abstract][Full Text] [Related]
7. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
[TBL] [Abstract][Full Text] [Related]
8. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
[TBL] [Abstract][Full Text] [Related]
9. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
11. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
[TBL] [Abstract][Full Text] [Related]
12. Cascade screening program for familial hypercholesterolemia.
Rubio-Marín P; Michán-Doña A; Maraver-Delgado J; Arroyo-Olivares R; Barrado Varea R; Pérez de Isla L; Mata P
Endocrinol Diabetes Nutr (Engl Ed); 2018 May; 65(5):280-286. PubMed ID: 29523491
[TBL] [Abstract][Full Text] [Related]
13. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
Wald DS; Bestwick JP
Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia.
Ajufo E; deGoma EM; Raper A; Yu KD; Cuchel M; Rader DJ
Genet Med; 2021 Sep; 23(9):1697-1704. PubMed ID: 34040191
[TBL] [Abstract][Full Text] [Related]
15. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
[TBL] [Abstract][Full Text] [Related]
16. Screening for familial hypercholesterolaemia in primary care: Time for general practice to play its part.
Brett T; Qureshi N; Gidding S; Watts GF
Atherosclerosis; 2018 Oct; 277():399-406. PubMed ID: 30270077
[TBL] [Abstract][Full Text] [Related]
17. Reverse Cascade Screening for Familial Hypercholesterolemia.
Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
[TBL] [Abstract][Full Text] [Related]
19. CaRe high - Cascade screening and registry for high cholesterol in Germany.
Schmidt N; Grammer T; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Laufs U; Otte B; Steinhagen-Thiessen E; Wanner C; März W
Atheroscler Suppl; 2017 Nov; 30():72-76. PubMed ID: 29096864
[TBL] [Abstract][Full Text] [Related]
20. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
